Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
From year to year, an increasing number of people face a wide range of gastrointestinal disorders and general health problems, often caused by an imbalance in the gastrointestinal microbiota. That is why developing products to normalize the state of the microflora is a priority in creating preventive health products. It has been established that products based on the gastrointestinal tract’s autochthonous microbiota are beneficial, technologically simple, and affordable, relying on lactobacilli, which are part of the normal human microflora.
From the perspective of marketing and the legal and regulatory framework, probiotic starter cultures are the best for development, as they can be used to produce many tasty and healthy food products that have all the necessary characteristics and are relatively inexpensive. The use of various species can contribute to new positive health effects and aid in the treatment of different diseases. Therefore, species like Limosilactobacillus reuteri, which is beneficial for human health and might be used in the treatment of various diseases, are interesting objects of study.
Michael Gänzle
Lviv Polytechnic National University
Life Sciences
Agriculture and Food; Biomanufacturing; Biotechnology
University of Alberta
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.